As Nxera Pharma proceeds into the “next era” implied by its name—following a rebrand from Sosei Group last year—the Japanese drugmaker is adding a new executive to help guide its growth plans. Kiyoshi ...
Exxon Mobil leads fresh analyst reports as Permian and Guyana output power growth, while Palantir's AI platforms and ...
As President Donald Trump’s tariff policies loom, global pharmaceutical giant AstraZeneca will invest $50 billion to boost its American manufacturing and R&D infrastructure. Chief among the company’s ...
AstraZeneca is London market's most valuable listed company Any departure would be latest blow to UK market The US is AstraZeneca's largest market July 1 (Reuters) - AstraZeneca (AZN.L), opens new tab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results